---
schema_version: "secwatch.filing_event.v1"
accession: "0001566469-24-000003"
form_type: "8-K"
ticker: null
cik: "0001566469"
company_name: "NantHealth, Inc."
filed_at: "2024-01-02T23:59:59+00:00"
generated_at: "2026-06-07T05:17:34.112676+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# NantHealth enters Second Supplemental Indenture waiving defaults, permitting Highbridge Settlement

## Summary
- Second Supplemental Indenture dated Dec 26, 2023 amends Convertible Notes Indenture to permit Highbridge Settlement, waive all existing defaults, and increase flexibility for future dispositions.
- Waiver covers all Defaults and Events of Default occurring as of Dec 26, 2023 under the Convertible Notes Indenture.
- Increased flexibility for future Dispositions (asset sales) as defined in the Indenture.

## SEC filing metadata
- accession: 0001566469-24-000003
- form_type: 8-K
- cik: 0001566469
- company_name: NantHealth, Inc.
- filed_at: 2024-01-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1566469/000156646924000003/0001566469-24-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1566469/000156646924000003/nh-20231226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001566469-24-000003
- JSON: https://secwatch.observer/filing/0001566469-24-000003.json
- Plain text: https://secwatch.observer/filing/0001566469-24-000003.txt

## Key facts
- Debt Financings
  NantHealth, Inc. amended convertible notes of Not specified in excerpt with U.S. Bank Trust Company, National Association at Not specified in excerpt maturing Not specified in excerpt.
  - Instrument: convertible notes
  - Principal: Not specified in excerpt
  - Counterparty: U.S. Bank Trust Company, National Association
  - Rate: Not specified in excerpt
  - Maturity: Not specified in excerpt
  - Event: amendment
  source text: On December 26, 2023, NantHealth, Inc. (the “ Company ”), NaviNet, Inc. and The OpenNMS Group, Inc. as subsidiary guarantors, and U.S. Bank Trust Company, National Association, as trustee and notes collateral agent, entered into a Second Supplemental Indenture (the “ Second Supplemental Indenture ”), which amends that certain Indenture, dated as of April 27, 2021 (as amended and restated by the First Supplemental Indenture, dated May 17, 2023, the “ Convertible Notes Indenture ”) to, among other things, (i) permit the transactions disclosed in the Company’s Current Report on Form 8-K filed on December 21, 2023 (the “ Highbridge Settlement ”), (ii) waive all Defaults and Events of Default (as each term is defined in the Convertible Notes Indenture) that have occurred or are occurring as of the date of the Second Supplemental Indenture, and (iii) increase flexibility for future Dispositions (as defined in the Convertible Notes Indenture).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1566469/000156646924000003/0001566469-24-000003-index.htm
- Material Agreements
  NantHealth, Inc. amended Second Supplemental Indenture to Convertible Notes Indenture dated April 27, 2021 with U.S. Bank Trust Company, National Association valued at Second Supplemental Indenture amends Convertible Notes Indenture to permit Highbridge Settlement, wa (effective 2023-12-26).
  - Action: amendment
  - Agreement: notes offering
  - Counterparty: U.S. Bank Trust Company, National Association
  - Value: Second Supplemental Indenture amends Convertible Notes Indenture to permit Highbridge Settlement, wa
  - Effective: 2023-12-26
  source text: On December 26, 2023, NantHealth, Inc. (the “ Company ”), NaviNet, Inc. and The OpenNMS Group, Inc. as subsidiary guarantors, and U.S. Bank Trust Company, National Association, as trustee and notes collateral agent, entered into a Second Supplemental Indenture (the “ Second Supplemental Indenture ”), which amends that certain Indenture, dated as of April 27, 2021 (as amended and restated by the First Supplemental Indenture, dated May 17, 2023, the “ Convertible Notes Indenture ”) to, among other things, (i) permit the transactions disclosed in the Company’s Current Report on Form 8-K filed on December 21, 2023 (the “ Highbridge Settlement ”), (ii) waive all Defaults and Events of Default (as each term is defined in the Convertible Notes Indenture) that have occurred or are occurring as of the date of the Second Supplemental Indenture, and (iii) increase flexibility for future Dispositions (as defined in the Convertible Notes Indenture).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1566469/000156646924000003/0001566469-24-000003-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.